Baxter International (NYSE:BAX) Receives New Coverage from Analysts at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Baxter International (NYSE:BAX – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued a neutral rating and a $36.00 price objective on the medical instruments supplier’s stock. Several other equities analysts also recently issued reports on BAX. Bank of America raised […]

Leave a Reply

Your email address will not be published.

Previous post Milestone Pharmaceuticals’ (MIST) Buy Rating Reaffirmed at HC Wainwright
Next post Celtics forward Jayson Tatum is looking beyond the past